全文获取类型
收费全文 | 7517篇 |
免费 | 595篇 |
国内免费 | 356篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 65篇 |
妇产科学 | 16篇 |
基础医学 | 256篇 |
口腔科学 | 37篇 |
临床医学 | 759篇 |
内科学 | 3743篇 |
皮肤病学 | 16篇 |
神经病学 | 224篇 |
特种医学 | 712篇 |
外国民族医学 | 1篇 |
外科学 | 860篇 |
综合类 | 1051篇 |
预防医学 | 125篇 |
眼科学 | 70篇 |
药学 | 241篇 |
6篇 | |
中国医学 | 39篇 |
肿瘤学 | 184篇 |
出版年
2024年 | 11篇 |
2023年 | 143篇 |
2022年 | 242篇 |
2021年 | 376篇 |
2020年 | 341篇 |
2019年 | 284篇 |
2018年 | 343篇 |
2017年 | 258篇 |
2016年 | 318篇 |
2015年 | 341篇 |
2014年 | 595篇 |
2013年 | 583篇 |
2012年 | 417篇 |
2011年 | 474篇 |
2010年 | 404篇 |
2009年 | 432篇 |
2008年 | 386篇 |
2007年 | 447篇 |
2006年 | 352篇 |
2005年 | 289篇 |
2004年 | 258篇 |
2003年 | 207篇 |
2002年 | 217篇 |
2001年 | 146篇 |
2000年 | 100篇 |
1999年 | 86篇 |
1998年 | 111篇 |
1997年 | 97篇 |
1996年 | 68篇 |
1995年 | 52篇 |
1994年 | 36篇 |
1993年 | 14篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1987年 | 2篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有8468条查询结果,搜索用时 15 毫秒
101.
T. Maishman H. Sheikh P. Boger J. Kelly K. Cozens A. Bateman S. Davies M. Fay D. Sharland A. Jackson 《Clinical oncology (Royal College of Radiologists (Great Britain))》2021,33(5):e225-e231
AimsSelf-expanding metal stents provide rapid improvement of dysphagia in oesophageal cancer but are associated with complications. The aim of the present study was to test the effectiveness of an alternative treatment of combining biodegradable stents with radiotherapy.Materials and methodsA Simon two-stage single-arm prospective phase II trial design was used to determine the efficacy of biodegradable stents plus radiotherapy in patients with dysphagia caused by oesophagus cancer who were unsuitable for radical treatment. Fourteen patients were recruited and data from 12 were included in the final analyses.ResultsFive of 12 patients met the primary end point: one stent-related patient death; four further interventions for dysphagia within 16 weeks of stenting (41.7%, 95% confidence interval 15.2–72.3%). The median time to a 10-point deterioration of quality of life was 2.7 weeks. Nine patients died within 52 weeks of registration. The median time to death from any cause was 15.0 weeks (95% confidence interval 9.6–not reached).ConclusionThe high re-intervention observed, which met the pre-defined early stopping criteria, meant that the suggested alternative treatment was not sufficiently effective to be considered for a larger scale trial design. Further work is needed to define the place of biodegradable stents in the management of malignant oesophageal strictures. 相似文献
102.
103.
104.
105.
106.
《Journal of vascular and interventional radiology : JVIR》2022,33(10):1199-1206
PurposeTo compare the technical success of antegrade uteral stent (AUS) and retrograde ureteral stent (RUS) placements in patients with malignant ureteral obstruction (MUO) and to determine the predictors of technical failure of RUS.Materials and MethodsThis study retrospectively included 61 AUS placements (44 patients) performed under fluoroscopic guidance and 76 RUS placements (55 patients) performed under cystoscopic guidance in patients with MUO from January 2019 to December 2020. Technical success rates of the 2 techniques were compared using inverse probability of treatment weighting (IPTW) analysis. Logistic regression was used to identify predictive factors for technical failures.ResultsTechnical success was achieved in 98.4% of the AUS group and 47.4% of the RUS group. After stabilized IPTW, the technical success rate was higher in the AUS group than in the RUS group (adjusted risk difference, 49.4%; 95% confidence interval [CI], 35.4%–63.1%). The independent predictors for technical failure of the RUS procedure were age of ≥65 years (odds ratio [OR], 5.56; 95% CI, 1.73–21.27), ureteral orifice invasion (OR, 4.21; 95% CI, 1.46–13.46), and extrinsic cancer (OR, 15.58; 95% CI, 2.92–111.81).ConclusionsThe technical success rate of AUS placement was higher than that of RUS placement in patients with MUO. RUS failure was associated with age of ≥65 years, cancer with ureteral orifice invasion, and extrinsic ureteral obstruction. 相似文献
107.
108.
109.
Colin D. Chue MRCP Helen C. Routledge MD MRCP Peter F. Ludman MD FRCP Jonathan N. Townend MD FRCP Andrew C.R. Epstein DPhil MRCP Nigel P. Buller MD FRCP Sagar N. Doshi MD FRCP 《Catheterization and cardiovascular interventions》2010,75(4):605-613
Objectives : To determine the 3 year safety and efficacy of crush‐stenting with paclitaxel‐eluting stents. Background : The optimum two‐stent strategy for treatment of coronary bifurcation lesions is undetermined. Crush‐stenting is advocated to minimize restenosis through complete circumferential stent coverage; long‐term follow‐up data are lacking. Methods and Results : In a single center prospective registry, 100 consecutive patients with bifurcation lesions were treated with the Crush technique. The vast majority (93%) were true bifurcations, predominantly involving the left anterior descending and diagonal arteries. Technical success was 98%. Final kissing balloon dilatation, which became standard practice during the study, was attempted in 68 patients and successful in 51. Abciximab was used in all cases. There were no peri‐procedural stent thromboses. Follow‐up was 100% at 3 years. Symptom‐driven target lesion revascularisation was 8% at 3 years. Cumulative 3‐year major adverse cardiac events was 28% (7 cardiac deaths, 15 myocardial infarctions, 11 target vessel revascularisations). Absence of a final kissing inflation predicted repeat revascularisation but not death, infarction or stent thrombosis. Three probable stent thromboses occurred, of which two were very late. Conclusion : Where a two‐stent bifurcation strategy is required, Crush‐stenting with paclitaxel‐eluting stents is safe and effective in the long‐term. Failure to perform a final kissing dilatation increases the likelihood of revascularisation but not other adverse events. © 2009 Wiley‐Liss, Inc. 相似文献